Qingzuan Supply Chain has signed a strategic agreement with Suzhou-headquartered AJJ to jointly invest 1 billion yuan ($142 million). In a separate development, Shenzhen Capital Group has co-led a $14 million funding in biotech startup Zhimeng Biopharma.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
